Design, Development, and Method Evaluation of Aptamer-Based Diagnostics for the Detection of Multidrug-Resistant Bacteria
Bacterial multidrug resistance poses a growing hazard to public health worldwide. <i>Pseudomonas aeruginosa</i> is a ubiquitous bacterial species that has been identified as the second most critical pathogen on the list of drug-resistant bacteria posing a huge threat to human health. <...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-04-01
|
| Series: | Proceedings |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2504-3900/103/1/39 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Bacterial multidrug resistance poses a growing hazard to public health worldwide. <i>Pseudomonas aeruginosa</i> is a ubiquitous bacterial species that has been identified as the second most critical pathogen on the list of drug-resistant bacteria posing a huge threat to human health. <i>P. aeruginosa</i> is an opportunistic Gram-negative bacterium that rapidly produces multiple virulence factors that promote adhesion, host cell penetration, and pathogenicity. It possesses inherent resistance to multiple classes of antibiotics, evading antibiotic treatment by triggering the persister phenotype. Traditional approaches for detecting pathogens in laboratory and clinical settings primarily involve microbiological, nucleic acid-based, immunological, and sequencing techniques, among others. These procedures are time-consuming, necessitate advanced laboratory equipment and skilled staff, and incur large setup costs, rendering them unsuitable for on-the-spot detection of bacterial infections in settings with limited resources. Aptasensors utilize nucleic acid aptamers as bio-receptors to detect pathogens. They circumvent the existing limitations of conventional detection systems due to their sensitivity, versatility for modification, cost-efficiency, and ability to enable real-time detection. So far, as per the literature, three aptamers have been developed against <i>P. aeruginosa</i> using whole bacterial cells but with unreported binding sites. This study aims to identify highly specific aptamers that can bind specifically to <i>P. aeruginosa</i> using whole-bacterium SELEX at any stage of growth with an extensive study of binding site interaction and identification. The objective is to develop an aptamer-based kit enabling rapid point-of-care detection of <i>P. aeruginosa</i> in clinical and environmental samples. |
|---|---|
| ISSN: | 2504-3900 |